The COMBAT HBV Feasibility Trial
Conditions: Hepatitis B; Vertical Transmission of Infectious Disease Interventions: Drug: Tenofovir Disoproxil Fumarate 300 MG; Biological: Hepatitis B monovalent vaccine; Drug: Placebo Sponsors: University of North Carolina, Chapel Hill; Doris Duke Charitable Foundation; Université Protestant au Congo; Abbott; Albert Einstein College of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials